Literature DB >> 1590667

Metabolic effects and disposition of sebacate, an alternate dicarboxylic fuel substrate.

A V Greco1, G Mingrone, C Raguso, A Tataranni, E Finotti, R M Tacchino, E Capristo, A De Gaetano, M Castagneto.   

Abstract

Disodium sebacate is a 10-carbon-atom dicarboxylic acid, proposed as substrate for parenteral nutrition. We investigated its pharmacokinetic profile and thermogenic effect during a short-time infusion (5 h at 10 g/h) in 7 male volunteers. Sebacate in serum and urine was measured by high-performance liquid chromatography. A single-compartment model with two linear elimination routes was fitted. Metabolic measurements (VO2, VCO2, respiratory quotient, metabolic rate) were continuously performed for 8 h (5 h during and 3 h after the infusion) by a canopy indirect calorimeter. The apparent volume of distribution of sebacate was 8.39 +/- 0.69 liters, and the plasma fractional removal rate constant was 0.0086 +/- 0.00077 min-1. The average half-life and plasma clearance were 80.6 min and 72 ml/min, respectively. The increase in metabolic rate, the decrease in respiratory quotient and the changes in ketone body, glucagon and insulin levels during the infusion were not significant. 24-hour catecholamine excretion was within normal limits. Calories administered by sebacate seem to be available for utilization without relevant metabolic side effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590667     DOI: 10.1159/000177693

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  2 in total

Review 1.  Use of dicarboxylic acids in type 2 diabetes.

Authors:  Geltrude Mingrone; Lidia Castagneto-Gissey; Katherine Macé
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Effect of oral sebacic Acid on postprandial glycemia, insulinemia, and glucose rate of appearance in type 2 diabetes.

Authors:  Amerigo Iaconelli; Amalia Gastaldelli; Chiara Chiellini; Donatella Gniuli; Angela Favuzzi; Christophe Binnert; Katherine Macé; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2010-08-19       Impact factor: 17.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.